IRIS
LAUDICELLA, Riccardo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.441
NA - Nord America 1.245
AS - Asia 588
SA - Sud America 188
AF - Africa 13
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.479
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.225
IE - Irlanda 420
SE - Svezia 372
IT - Italia 354
SG - Singapore 322
BR - Brasile 165
CN - Cina 126
DE - Germania 65
PL - Polonia 51
IN - India 50
FI - Finlandia 27
FR - Francia 26
GB - Regno Unito 24
BE - Belgio 22
AT - Austria 20
ID - Indonesia 14
NL - Olanda 13
HK - Hong Kong 12
LT - Lituania 11
CA - Canada 10
IR - Iran 10
AR - Argentina 8
VN - Vietnam 8
TR - Turchia 6
VE - Venezuela 6
ES - Italia 5
MX - Messico 5
UZ - Uzbekistan 5
ZA - Sudafrica 5
AZ - Azerbaigian 4
GE - Georgia 4
IL - Israele 4
IQ - Iraq 4
NO - Norvegia 4
PE - Perù 4
PT - Portogallo 4
RU - Federazione Russa 4
AE - Emirati Arabi Uniti 3
CH - Svizzera 3
PH - Filippine 3
UA - Ucraina 3
AU - Australia 2
CL - Cile 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
EC - Ecuador 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
MA - Marocco 2
PA - Panama 2
RO - Romania 2
SA - Arabia Saudita 2
AL - Albania 1
BD - Bangladesh 1
BW - Botswana 1
BY - Bielorussia 1
DZ - Algeria 1
EG - Egitto 1
EU - Europa 1
GR - Grecia 1
HR - Croazia 1
HU - Ungheria 1
JM - Giamaica 1
JO - Giordania 1
JP - Giappone 1
LK - Sri Lanka 1
MK - Macedonia 1
MU - Mauritius 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PK - Pakistan 1
PY - Paraguay 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TH - Thailandia 1
TN - Tunisia 1
TW - Taiwan 1
Totale 3.479
Salva come PNG Salva come JPEG
Città #
Dublin 418
Chandler 413
Nyköping 288
Singapore 170
Messina 113
Princeton 74
Ashburn 70
Medford 61
Warsaw 51
Bremen 37
Des Moines 35
Beijing 30
Los Angeles 30
Rome 28
Hyderabad 27
Helsinki 26
Brussels 22
Jacksonville 19
Dearborn 17
Palermo 17
São Paulo 17
Vienna 13
Boardman 12
Hong Kong 12
Jakarta 12
Jinan 12
Nuremberg 12
Seattle 11
Ann Arbor 10
Nanjing 10
Pune 10
Genoa 9
Mumbai 9
Dong Ket 8
Rio de Janeiro 8
Hangzhou 7
London 7
Milan 7
Nanchang 7
The Dalles 7
Tianjin 7
Wilmington 7
Munich 6
Redwood City 6
Shenyang 6
Barcellona Pozzo di Gotto 5
Brasília 5
Campinas 5
Ottawa 5
Santa Domenica 5
Tashkent 5
Torregrotta 5
Zhengzhou 5
Baku 4
Cagliari 4
Cambridge 4
Catania 4
Curitiba 4
Florence 4
Fuzhou 4
Istanbul 4
Lima 4
San Mateo 4
São José do Rio Preto 4
Tbilisi 4
Toronto 4
Waverly Hall 4
Anaheim 3
Augusta 3
Cardito 3
Caxias do Sul 3
Changsha 3
Frankfurt am Main 3
Haikou 3
Johannesburg 3
Mislata 3
Oslo 3
Ourinhos 3
Qingdao 3
Ribeirão Preto 3
Rometta Marea 3
Taiyuan 3
Taizhou 3
Tel Aviv 3
Temple 3
Zurich 3
Amsterdam 2
Baghdad 2
Bari 2
Bologna 2
Cerquilho 2
Chengdu 2
Chicago 2
Diadema 2
Edinburgh 2
Fairfield 2
Fara Gera d'Adda 2
Fiumefreddo Di Sicilia 2
Hebei 2
Iasi 2
Totale 2.359
Salva come PNG Salva come JPEG
Nome #
Artificial intelligence in molecular imaging: from machine to deep learning 130
PRRT Retreatments: Renal Function Evaluation 102
Prognostic Validity of Dual Tracer PET/CT in the PRRT Enrollment of GEP-NET Patients 92
Peptide Receptor Radionuclide Therapy and Somatostatin 'cold' Analogues Therapy in the Treatment of GEP-NET Patients: Our Center’ Experience 89
Effectiveness, safety and haematological toxicity of 223Ra-Cl2: a single centre experience 79
Safety, effectiveness and haematological toxicity of 223Radichloride: a single Centre experience 78
Complete Response in a Pancreatic Nen with Liver Metastasis after PRRT in association with Lanreotide Autogel/depot: Design of the Prelude Study 78
[68 Ga]DOTATOC PET/CT Radiomics to Predict the Response in GEP-NETs Undergoing [177 Lu]DOTATOC PRRT: The “Theragnomics” Concept 77
A Single Centre Experience with 223-Radium-Dichloride ((RaCl2)-Ra-223) Therapy 75
Serial scanning with 99mTc-3, 3-diphosphono-1, 2-propanodicarboxylic acid (99mTc-DPD) for early detection of cardiac amyloid deposition and prediction of clinical worsening in subjects carrying a transthyretin gene mutation 75
18F-FDG PET/CT Imaging of Immune Checkpoint Inhibitor-Related "Retroperitoneal Panniculitis" 74
Dual Time-Point FET-PET/CT in Glioma Patients: a Single-Centre Preliminary Experience 72
Peptide receptor radionuclide therapy for aggressive pituitary tumors: a monocentric experience 71
223RA-dichloride use in patients affected by bone metastases from castration-resistant prostate cancer: single centre experience 71
Clinico-laboratory response and haematological toxicity in patients undergoing therapy with 223RA-dichloride 70
Complete response in a pancreatic NEN with liver metastasis after PRRT in association with lanreotide autogel/depot 70
Diagnosis of cardiac amyloid transthyretin (ATTR) amyloidosis by early (soft tissue) phase [99mTc]Tc-DPD whole body scan: comparison with late (bone) phase imaging 70
Differentiating malignant from benign thyroid nodules with indeterminate cytology by 99mTc-MIBI scan: A new quantitative method for improving diagnostic accuracy 69
Renal Function Evaluation in PRRT Retreatments 68
COVID-19 Surface Persistence: A Recent Data Summary and Its Importance for Medical and Dental Settings 67
Prognostic and diagnostic value of [18F]FDG-PET/CT in restaging patients with small cell lung carcinoma: an Italian multicenter study 65
PRRT retreatments: renal function evaluation 60
Prognostic Validity of Dual Tracer PET/CT In The PRRT Enrollment of GEP-NET Patients 59
Comparing radioiodine abdominal absorbed dose in differentiated thyroid cancer patients undergone thyroid remnant ablation in either levo-thyroxine withdrawal or after rhtsh stimulation 58
Is dual tracer PET/CT a prognostic biomarker in the PRRT enrollment of GEP-NET patients? 58
Prevalence of interstitial pneumonia suggestive of COVID-19 at 18F-FDG PET/CT in oncological asymptomatic patients in a high prevalence country during pandemic period: a national multi-centric retrospective study 58
18F-FACBC in prostate cancer: A systematic review and meta-analysis 54
PSMA and Choline PET for the Assessment of Response to Therapy and Survival Outcomes in Prostate Cancer Patients: A Systematic Review from the Literature 53
Correction to: 18F-FMISO PET imaging: insights over MRI in patients with glioma (Clinical and Translational Imaging, (2020), 8, 1, (3-10), 10.1007/s40336-019-00353-0) 52
Peptide receptor radionuclide therapy (PRRT) in patients with giant aggressive pituitary tumors: experience of an Italian referral center and review of literature 51
Artifcial intelligence applications in SSTR targeted PET/CT images: prediction of response assessment in GEP-NETs undergoing PRRT with [177Lu]DOTATOC 51
Non-invasive cardiac imaging in patients with systemic amyloidosis: a practical approach with emphasis on clinical contribution of bone-seeking radiotracers 50
Peptide Receptor Radionuclide Therapy of Pulmonary Neuroendocrine Neoplasms: a Single-Centre Experience 50
The utility of dual time-point FET-PET/CT in recurrence assessment of glioma patients 50
The additional value of 18F-FDG PET and MRI in patients with glioma: A review of the literature from 2015 to 2020 48
18F-FDG PET/MR Refines Evaluation in Newly Diagnosed Metastatic Urethral Adenocarcinoma 48
[177Lu]Lu-DOTA-TATE versus standard of care in adult patients with gastro-enteropancreatic neuroendocrine tumours (GEP-NETs): a cost-consequence analysis from an Italian hospital perspective 46
Sars-cov-2 persistence: data summary up to q2 2020 46
Artificial intelligence applications in 68Ga-DOTA PETICT images: Prediction of response assessment in GEP-NETs undergoing PRRT with 177Lu-DOTATOC 46
Unconventional non-amino acidic PET radiotracers for molecular imaging in gliomas 45
Radiomics Analysis of Brain [18 F]FDG PET/CT to Predict Alzheimer’s Disease in Patients with Amyloid PET Positivity: A Preliminary Report on the Application of SPM Cortical Segmentation, Pyradiomics and Machine-Learning Analysis 45
Subcutaneous Uptake on [18F]Florbetaben PET/CT: a Case Report of Possible Amyloid-Beta Immune-Reactivity After COVID-19 Vaccination 43
Artificial neural networks in cardiovascular diseases and its potential for clinical application in molecular imaging 42
Prognostic insights of molecular imaging in cardiac sarcoidosis 41
[18F] Fluorothymidine Positron Emission Tomography Imaging in Primary Brain Tumours: A Systematic Review 40
Imaging gastrin-releasing peptide receptors (GRPRs) in prostate cancer 38
Malignant cutaneous melanoma: Updates in PET imaging 38
PET/MR in neuro-oncology: is it ready for prime-time? 38
Artificial Intelligence Applications on Restaging [18F]FDG PET/CT in Metastatic Colorectal Cancer: A Preliminary Report of Morpho-Functional Radiomics Classification for Prediction of Disease Outcome 37
Emerging applications of imaging in glioma: focus on PET/MRI and radiomics 37
The Utility of Conventional Amino Acid PET Radiotracers in the Evaluation of Glioma Recurrence Also in Comparison with MRI 37
Combined use of peptide receptor radionuclide therapy and metronomic chemotherapy in neuroendocrine tumors: a possible choice driven by nuclear medicine molecular imaging 36
The prognostic power of 18F-FDG PET/CT extends to estimating systemic treatment response duration in metastatic castration-resistant prostate cancer (mCRPC) patients 34
Correction to: Diagnosis of cardiac amyloid transthyretin (ATTR) amyloidosis by early (soft tissue) phase [99mTc]Tc-DPD whole body scan: comparison with late (bone) phase imaging 32
Molecular imaging of pancreatic neoplasms 32
Undetectable or low (< 1 ng/ml) postsurgical thyroglobulin values do not rule out metastases in early stage differentiated thyroid cancer patients 29
Prostate Cancer Biochemical Recurrence Resulted Negative on [68Ga]Ga-PSMA-11 but Positive on [18F]Fluoromethylcholine PET/CT 27
Preliminary Findings of the Role of FAPi in Prostate Cancer Theranostics 27
Recombinant human thyrotropin (rhTSH) versus Levo-thyroxine withdrawal in radioiodine therapy of differentiated thyroid cancer patients: differences in abdominal absorbed dose 24
null 23
Response prediction to PRRT in progressing and metastatic GEP-NET undergoing restaging 68Ga-DOTA PETICT: A preliminary multicenter radiomics study 22
State of the art of 18F-FDG PET/CT application in inflammation and infection: a guide for image acquisition and interpretation 21
Monitoring of cardiac transthyretin amyloid load by [Tc-99m]DPD scintigraphy: is it the end of the semi-quantitative evaluation? 19
Radiomics and artificial intelligence in prostate cancer: new tools for molecular hybrid imaging and theragnostics 17
The role of PET radiomic features in prostate cancer: a systematic review 16
null 16
Combined forced diuresis and late acquisition on [68Ga]Ga-PSMA-11 PET/CT for biochemical recurrent prostate cancer: a clinical practice-oriented study 14
FAPi-Based Agents in Thyroid Cancer: A New Step towards Diagnosis and Therapy? A Systematic Review of the Literature 12
Artificial intelligence in molecular imaging: from machine to deep learning 10
PET Imaging in Gliomas: Clinical Principles and Synergies with MRI 10
From bench to bedside: highlights from the International Dialogue on Ovarian Cancer 10
Infiltrative growth pattern of prostate cancer is associated with lower uptake on PSMA PET and reduced diffusion restriction on mpMRI 10
[18F]FDG PET/CT criteria for treatment response assessment: EORTC and beyond 9
Correction: PSMA‑positive prostatic volume prediction with deep learning based on T2‑weighted MRI 9
Head-to-Head Comparison of FDG and Radiolabeled FAPI PET: A Systematic Review of the Literature 9
PET-based artificial intelligence applications in cardiac nuclear medicine 9
Prostate-Specific Membrane Antigen Positron Emission Tomography Oncological Applications beyond Prostate Cancer in Comparison to Other Radiopharmaceuticals 8
Choline PET/CT features to predict survival outcome in high-risk prostate cancer restaging: a preliminary machine-learning radiomics study 8
PET Criteria by Cancer Type from Imaging Interpretation to Treatment Response Assessment: Beyond FDG PET Score 8
An Overview of In Vitro Assays of 64Cu-, 68Ga-, 125I-, and 99mTc-Labelled Radiopharmaceuticals Using Radiometric Counters in the Era of Radiotheranostics 7
A Multimodal Clinical Approach for the Treatment of Bone Metastases in Solid Tumors 7
[11C]Choline PET/CT in a Patient with Prostate Cancer Biochemical Recurrence Showing Two Suspicious Findings in the Breast and Liver 7
68Ga-PSMA-11 PET/MRI versus multiparametric MRI in men referred for prostate biopsy: primary tumour localization and interreader agreement 7
ChatGPT in nuclear medicine and radiology: lights and shadows in the AI bionetwork 6
Reply to Perera Molligoda Arachchige AS [1] 6
Quantitative imaging parameters to predict the local staging of prostate cancer in intermediate- to high-risk patients 6
The Future of Cancer Diagnosis, Treatment and Surveillance: A Systemic Review on Immunotherapy and Immuno-PET Radiotracers 6
Can We Predict Skeletal Lesion on Bone Scan Based on Quantitative PSMA PET/CT Features? 6
Advantages of SiPM-based digital PET/CT technology in nuclear medicine clinical practice: a systematic review– part 2 5
PSMA-positive prostatic volume prediction with deep learning based on T2-weighted MRI 5
Immunohistochemical ERG positivity is associated with decreased PSMA expression and lower visibility in corresponding [68Ga]Ga-PSMA-11 PET scans of primary prostate cancer 5
A Review of Advances in Molecular Imaging of Rheumatoid Arthritis: From In Vitro to Clinic Applications Using Radiolabeled Targeting Vectors with Technetium-99m 5
The role of PSMA-based radioligand therapy in hormone-sensitive prostate cancer 5
Non-conventional and Investigational PET Radiotracers for Breast Cancer: A Systematic Review 5
Is There a Role of Interim PSMA PET in Chemotherapy of Prostate Cancer? 5
Advantages of SiPM-based digital PET/CT technology in nuclear medicine clinical practice: a systematic review—Part 1 oncological setting 5
The Added Value of [18F]Choline PET/CT in Low-Risk Prostate Cancer Staging: A Case Report 4
mCRPC progression of disease after [177Lu]Lu-PSMA-617 detected on [18F]Choline: a case of PCa heterogeneity 4
The Role of Theragnostics in Breast Cancer: A Systematic Review of the Last 12 Years 4
Applications of Artificial Intelligence and Radiomics in Molecular Hybrid Imaging and Theragnostics for Neuro-Endocrine Neoplasms (NENs) 4
Totale 3.676
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.680
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.680
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202066 0 0 0 0 0 0 0 0 3 23 11 29
2020/2021259 22 5 60 6 29 13 12 14 43 27 17 11
2021/2022464 6 30 4 22 31 13 27 34 6 54 35 202
2022/20231.387 119 196 70 107 91 140 17 89 482 16 36 24
2023/2024369 41 39 22 33 43 50 13 31 9 32 16 40
2024/20251.065 12 59 45 75 153 64 154 317 186 0 0 0
Totale 3.689